EBR Systems(EBRCZ)
SUNNYVALE, CABiotechnology
Focus: EBR Systems is a publicly traded medical device company focused on wireless cardiac stimulation technology for heart failure treatment. The company operates at a pre-commercial stage with minimal revenue ($2M in FY 2025) but significant R&D investment.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
20+10 this month
Growing — net +10 jobs in 30d
16 jobs added vs 6 removed. Steady team buildout.
Should You Work at EBR Systems?
AI assessmentEBR Systems presents a high-risk, high-reward opportunity for technologists and clinical innovators willing to bet on a pre-revenue device platform with strong IP but precarious near-term cash position.
Why Work Here
- Early-stage medical device innovation with proprietary wireless cardiac stimulation platform (WiSE/WiCS-LV systems) addressing large heart failure market.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$2M
Pipeline & Clinical Trials
WiCS-LV System
Cardiac Resynchronization TherapyClinical Trials (1)
NCT02610673WiCS-LV Post Market Surveillance Registry
N/AHelp build intelligence for EBR Systems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.